Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2022-12-19
- Lead Sponsor
- NovaCell Technology Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05638165
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
News
No news found